RecruitingNontuberculous Mycobacterium Infection
IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)
Eligible age
18+ yrs
Accepts
All genders
Locations
10 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to assess the safety and tolerability of two 5-day infusion cycles of IV gallium in adult patients with CF who are infected with NTM. Funding Source - FDA Office of Orphan Products Development (OOPD)
Sponsor: Chris Goss
You may qualify if…
- ✓ 1. Written informed consent obtained from participant or participant's legal representative
- ✓ 2. Be willing and able to adhere to the study visit schedule and other protocol requirements
- ✓ 3. All genders ≥ 18 years of age at Visit 1
- ✓ 4. Documentation of a CF diagnosis as evidenced by one or more clinical features consistent with the CF phenotype
- ✓ 5. Documentation of persistently positive NTM culture results that are positive for the same species or sub-species (either M. avium complex, M. abscessus complex, or both M. avium and M. abscessus). Persistently positive cultures are those which meet ONE of the following criteria, after first ignoring any negative culture results that occur within 7 days of a positive culture:
- ✓ 1. The two most recent NTM culture results from sputum or BAL taken at least 28 days apart are positive.
- ✓ OR
- ✓ 2. At least one NTM culture result in the previous 4 months from sputum or BAL is positive. If there are four or more cultures in the last 12-months at least 3 out of the 4 most recent cultures must be positive for NTM. If there are three or fewer cultures in the past 12 months, then at least 2 of the 3 most recent cultures must be positive for NTM even if some of those cultures are more than 12 months ago.
You may not qualify if…
- ✕ 1. Any of the following abnormal lab values at screening:
- ✕ Hemoglobin \<10g/dL
- ✕ Platelets \<100,000/mm3
- ✕ Absolute neutrophil count \< 1500/mm3
- ✕ Aspartate transaminase (AST), alanine transaminase (ALT), gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP), or total bilirubin ≥3 x upper limit of normal
- ✕ Serum creatinine \> 2.0 mg/dl and ≥1.5 x upper limit of normal
- ✕ Ionized calcium ≤ lower limit of normal (only performed if total calcium is ≤ lower limit of normal)
- ✕ 2. History of solid organ or hematological transplantation
Where it's recruiting
Alabama
Birmingham
Colorado
Denver
Maryland
Baltimore
Minnesota
Minneapolis
Ohio
Columbus
Pennsylvania
Pittsburgh
South Carolina
Charleston
Texas
Dallas
Vermont
Burlington
Washington
Seattle
Source: ClinicalTrials.gov · NCT04294043 · last updated 2025-10-01